SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · Artiva Biotherapeutics priced a $300M underwritten public offering of…

Artiva Biotherapeutics, Inc. · 8-K filed May 8, 2026 at 16:24 ET

At the news

BEARISHIMPACT 7/10

8-K filed May 8, 2026 at 16:24 ET

Artiva Biotherapeutics priced a $300M underwritten public offering of 23.9M shares and pre-funded warrants for 2.2M shares at $11.52 per share, equating to roughly 100% dilution of existing shares. The massive capital raise signals urgent cash needs for a pre-revenue biotech and will severely dilute existing shareholders.

  • Offering of 23,871,526 shares and 2,170,138 pre-funded warrants for common stock
  • Price: $11.52 per share; $11.5199 per pre-funded warrant
  • Gross proceeds approximately $300 million
  • Closing expected May 11, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access